Is Quanterix Corp (QTRX) Halal?
Shariah Screening — 5 Standards
Based on financial data from December 2025
| Standard | Debt Ratio | Cash Ratio | Receivables | Income | Status |
|---|---|---|---|---|---|
| AAOIFI | 15.8% / 30% | 122.3% / 30% | 13.6% / 30% | 10.82% / 5% | ✗ NOT HALAL |
| DJIM | 15.8% / 33% | 122.3% / 33% | 13.6% / 33% | 10.82% / 5% | ✗ NOT HALAL |
| MSCI | 9.2% / 33% | 71.1% / 33% | 7.9% / 33% | 10.82% / 5% | ✗ NOT HALAL |
| S&P | 15.8% / 33% | 122.3% / 33% | 13.6% / 33% | 10.82% / 5% | ✗ NOT HALAL |
| FTSE | 9.2% / 33% | 71.1% / 33% | 7.9% / 50% | 10.82% / 5% | ✗ NOT HALAL |
Financial Highlights
Profitability
| Gross Margin | 46.8% | |
| Operating Margin | -48.2% | |
| Net Margin | -77.1% | |
| Return on Equity (ROE) | -34.2% | |
| Return on Assets (ROA) | -13.1% |
Cash Flow & Balance Sheet
| Operating Cash Flow | -$77M |
| Free Cash Flow | -$80M |
| Total Debt | $37M |
| Debt-to-Equity | 12.6 |
| Current Ratio | 2.8 |
| Total Assets | $419M |
Price & Trading
| Last Close | $3.90 |
| 50-Day MA | $5.73 |
| 200-Day MA | $5.85 |
| Avg Volume | 645K |
| Beta | 1.1 |
|
52-Week Range
$3.52
| |
About Quanterix Corp (QTRX)
Quanterix Corporation, a life sciences company in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company offers HD-X instrument, a protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection in an expanded range of applications. It also provides SP-X instrument that is based on Simoa planar array technology for the measurement of multiplex chemiluminescent immunoassays. The company's products include assays include all components required to run enzyme-based immunoassay, such as beads, capture and detector reagents, and enzyme reagents and substrate; and replacement parts, reagents, and antibodies. In addition, the company offers contract research and clinical laboratory testing services, including research and clinical trial testing, and lucent diagnostic services. The company primarily operates in the areas of neurology, oncology and immunology, and inflammation. It sells its products for the life science research sector primarily to laboratories associated with academic and governmental research institutions, as well as pharmaceutical, biotechnology, and contract research companies through a direct field sale, support organizations, and sales force and distributors. The company was formerly known as Digital Genomics, Inc. and changed its name to Quanterix Corporation in August 2007. Quanterix Corporation was incorporated in 2007 and is headquartered in Billerica, Massachusetts.
Related Halal Stocks in Healthcare
Frequently Asked Questions
Is Quanterix Corp (QTRX) halal to invest in?
Based on our screening using AAOIFI Standard 21 (the strictest methodology), Quanterix Corp is Not Halal. The company fails one or more screening criteria. We screen against all 5 major standards: AAOIFI, DJIM, MSCI, S&P, and FTSE.
What is Quanterix Corp's debt ratio?
Quanterix Corp's debt ratio is 15.8% under the AAOIFI standard (which uses market capitalization as the denominator). The AAOIFI threshold is 30%. Under MSCI and FTSE (which use total assets as the denominator), the debt ratio is 9.2%.
What are Quanterix Corp's key financial metrics?
Quanterix Corp has a market capitalization of $168M, and revenue of $139M. The company maintains a gross margin of 46.8% and a net margin of -77.1%. Return on equity stands at -34.2%.
How often is the screening data updated?
Our screening data is updated regularly using the latest available financial statements and market data. Stock prices and market caps are refreshed frequently, while financial statements are updated quarterly when companies report earnings.
Disclaimer: HalalStockGuide.com provides Shariah compliance screening for educational and informational purposes only. This is not a fatwa, financial advice, or a recommendation to buy or sell any security. Screening results are based on publicly available financial data and established methodologies. Always consult a qualified Islamic scholar and a licensed financial advisor before making investment decisions.